Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Huo T-I, Lui W-Y, Wu J-C, et al. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. World J Surg. 2004;28(3):258–262. doi: 10.1007/s00268-003-7182-6.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–1236. doi: 10.1002/hep.20933.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108. doi: 10.3322/canjclin.55.2.74.
   PubMed Web of Science ®Google Scholar
• Hu B, Sun D, Sun C, et al. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Biochem Biophys Res Commun. 2015;468(4):525–532. doi: 10.1016/j.bbrc.2015.10.031.
   PubMed Web of Science ®Google Scholar
• Visvader JE. Cells of origin in cancer. Nature. 2011;469(7330):314–322. doi: 10.1038/nature09781.
   PubMed Web of Science ®Google Scholar
• Spano D, Heck C, De Antonellis P, et al. Molecular networks that regulate cancer metastasis. Semin Cancer Biol. 2012;22(3):234–249. doi: 10.1016/j.semcancer.2012.03.006.
   PubMed Web of Science ®Google Scholar
• Anderson RL, Balasas T, Callaghan J, et al. A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol. 2019;16(3):185–204. doi: 10.1038/s41571-018-0134-8.
   PubMed Web of Science ®Google Scholar
• Wilken R, Veena MS, Wang MB, et al. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011;10:12. doi: 10.1186/1476-4598-10-12.
   PubMed Web of Science ®Google Scholar
• Sharifi-Rad J, Rayess YE, Rizk AA, et al. Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Front Pharmacol. 2020;11:01021. doi: 10.3389/fphar.2020.01021.
   PubMed Web of Science ®Google Scholar
• Tian S, Liao L, Zhou Q, et al. Curcumin inhibits the growth of liver cancer by impairing myeloid‑derived suppressor cells in murine tumor tissues. Oncol Lett. 2021;21(4):286. doi: 10.3892/ol.2021.12547.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Ji C, Mayfield JE, et al. Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2. Proc Natl Acad Sci U S A. 2018;115(32):8155–8160. doi: 10.1073/pnas.1806797115.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang X, Zeng S, et al. The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2018;37(1):1–12. doi: 10.1186/s13046-018-0959-0.
   PubMedGoogle Scholar
• Zhang P, Lai Z-L, Chen H-F, et al. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in Colon cancer cells with tumor growth inhibition in xenograft mice. J Exp Clin Cancer Res. 2017;36(1):1–12. doi: 10.1186/s13046-017-0661-7.
   PubMedGoogle Scholar
• Wang L, Chen X, Du Z, et al. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics. J Exp Clin Cancer Res. 2017;36(1):1–14. doi: 10.1186/s13046-017-0513-5.
   PubMedGoogle Scholar
• Rana M, Maurya P, Reddy SS, et al. A standardized chemically modified curcuma longa extract modulates IRAK-MAPK signaling in inflammation and potentiates cytotoxicity. Front Pharmacol. 2016;7:223. doi: 10.3389/fphar.2016.00223.
   PubMed Web of Science ®Google Scholar
• Illuri R, Bethapudi B, Anandakumar S, et al. Anti-inflammatory activity of polysaccharide fraction of curcuma longa extract (NR-INF-02). Antiinflamm Antiallergy Agents Med Chem. 2015;14(1):53–62. doi: 10.2174/1871523014666150407150533.
   PubMedGoogle Scholar
• Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017;57(13):2889–2895. doi: 10.1080/10408398.2015.1077195.
   PubMed Web of Science ®Google Scholar
• S, Darvesh A, B, Aggarwal B, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol. 2012;13(1):218–228. doi: 10.2174/138920112798868791.
   PubMed Web of Science ®Google Scholar
• Uchio R, Higashi Y, Kohama Y, et al. A hot water extract of turmeric (curcuma longa) suppresses acute ethanol-induced liver injury in mice by inhibiting hepatic oxidative stress and inflammatory cytokine production. J Nutr Sci. 2017;6:e3. doi: 10.1017/jns.2016.43.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–818. doi: 10.1021/mp700113r.
   PubMed Web of Science ®Google Scholar
• Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg. 2021;8(1):34.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Mochida A, Choyke PL, et al. Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer? Bioconjug Chem. 2016;27(10):2225–2238. doi: 10.1021/acs.bioconjchem.6b00437.
   PubMed Web of Science ®Google Scholar
• Baek JS, Cho CW. A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells. Oncotarget. 2017;8(18):30369–30382. doi: 10.18632/oncotarget.16153.
   PubMedGoogle Scholar
• Zhao MD, Li JQ, Chen FY, et al. Co-Delivery of curcumin and paclitaxel by "Core-Shell" targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer. Int J Nanomed. 2019;14:9453–9467. doi: 10.2147/IJN.S224579.
   PubMed Web of Science ®Google Scholar
• Bian Y, Guo D. Targeted therapy for hepatocellular carcinoma: co-Delivery of sorafenib and curcumin using lactosylated pH-Responsive nanoparticles. Drug Des Devel Ther. 2020;14:647–659. doi: 10.2147/DDDT.S238955.
   PubMed Web of Science ®Google Scholar
• Verderio P, Bonetti P, Colombo M, et al. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells. Biomacromolecules. 2013;14(3):672–682. doi: 10.1021/bm3017324.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Meng P, Dai YQ, et al. PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur J Pharm Biopharm. 2008;70(3):749–757. doi: 10.1016/j.ejpb.2008.06.015.
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol. 2011;670(2–3):372–383. doi: 10.1016/j.ejphar.2011.09.023.
   PubMed Web of Science ®Google Scholar
• Anand P, Nair HB, Sung B, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol. 2010;79(3):330–338. doi: 10.1016/j.bcp.2009.09.003.
   PubMed Web of Science ®Google Scholar
• Kumari M, Sharma N, Manchanda R, et al. PGMD/curcumin nanoparticles for the treatment of breast cancer. Sci Rep. 2021;11(1):3824. doi: 10.1038/s41598-021-81701-x.
   PubMed Web of Science ®Google Scholar
• Saganuwan SA. A modified arithmetical method of reed and muench for determination of a relatively ideal median lethal dose. Afr J Pharm Pharmacol. 2011;5(12):1543–1546. doi: 10.5897/AJPP11.393.
   Google Scholar
• Gaballa R, Ali HEA, Mahmoud MO, et al. Exosomes-Mediated transfer of Itga2 promotes migration and invasion of prostate cancer cells by inducing Epithelial-Mesenchymal transition. Cancers (Basel). 2020;12(8):2300. doi: 10.3390/cancers12082300.
   PubMed Web of Science ®Google Scholar
• Lokman NA, Elder AS, Ricciardelli C, et al. Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. Int J Mol Sci. 2012;13(8):9959–9970. doi: 10.3390/ijms13089959.
   PubMed Web of Science ®Google Scholar
• Aldubayan MA, Elgharabawy RM, Ahmed AS, et al. Antineoplastic activity and curative role of avenanthramides against the growth of ehrlich solid tumors in mice. Oxid Med Cell Longev. 2019;2019:5162687. doi: 10.1155/2019/5162687.
   PubMed Web of Science ®Google Scholar
• El-Shitany NA, Abbas AT, Ali SS, et al. Nanoparticles ellagic acid protects against cisplatin-induced hepatotoxicity in rats without inhibiting its cytotoxic activity. Int J Pharmacol. 2019;15(4):465–477. doi: 10.3923/ijp.2019.465.477.
   Google Scholar
• Dei Cas M, Ghidoni R. Dietary curcumin: correlation between bioavailability and health potential. Nutrients. 2019;11(9):2147. doi: 10.3390/nu11092147.
   Web of Science ®Google Scholar
• Carolina Alves R, Perosa Fernandes R, Fonseca-Santos B, et al. A critical review of the properties and analytical methods for the determination of curcumin in biological and pharmaceutical matrices. Crit Rev Anal Chem. 2019;49(2):138–149. doi: 10.1080/10408347.2018.1489216.
   PubMed Web of Science ®Google Scholar
• Shome S, Talukdar AD, Choudhury MD, et al. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective. J Pharm Pharmacol. 2016;68(12):1481–1500. doi: 10.1111/jphp.12611.
   PubMed Web of Science ®Google Scholar
• Khalil NM, do Nascimento TC, Casa DM, et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Coll Surf B Biointer. 2013;101:353–360. doi: 10.1016/j.colsurfb.2012.06.024.
   PubMed Web of Science ®Google Scholar
• Sharma A, Hawthorne S, Jha SK, et al. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells. Nanomedicine (Lond). 2021;16(20):1763–1773. doi: 10.2217/nnm-2021-0066.
   PubMed Web of Science ®Google Scholar
• Arya G, Das M, Sahoo SK. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomed Pharmacother. 2018;102:555–566. doi: 10.1016/j.biopha.2018.03.101.
   PubMed Web of Science ®Google Scholar
• Verderio P, Pandolfi L, Mazzucchelli S, et al. Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells. Mol Pharm. 2014;11(8):2864–2875. doi: 10.1021/mp500222k.
   PubMedGoogle Scholar
• Liang H, Friedman JM, Nacharaju P. Fabrication of biodegradable PEG-PLA nanospheres for solubility, stabilization, and delivery of curcumin. Artif Cells Nanomed Biotechnol. 2017;45(2):297–304. doi: 10.3109/21691401.2016.1146736.
   PubMed Web of Science ®Google Scholar
• Duan J, Zhang Y, Han S, et al. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm. 2010;400(1–2):211–220. doi: 10.1016/j.ijpharm.2010.08.033.
   PubMedGoogle Scholar
• Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402–418. doi: 10.1016/j.apsb.2015.07.005.
   PubMed Web of Science ®Google Scholar
• Vargas A, Zeisser-Labouebe M, Lange N, et al. The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Rev. 2007;59(11):1162–1176. doi: 10.1016/j.addr.2007.04.019.
   PubMed Web of Science ®Google Scholar
• Nowak-Sliwinska P, Segura T, Iruela-Arispe ML. The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis. 2014;17(4):779–804. doi: 10.1007/s10456-014-9440-7.
   PubMed Web of Science ®Google Scholar
• de Carvalho FB, de Gomes MG, Savall ASP, et al. Evaluation of curcumin-loaded polymeric nanocapsules with different coatings in chick embryo model: influence on angiogenesis, teratogenesis and oxidative stress. Pharmacol Rep. 2021;73(2):563–573. doi: 10.1007/s43440-021-00218-2.
   PubMed Web of Science ®Google Scholar
• Dragostin OM, Tatia R, Samal SK, et al. Designing of chitosan derivatives nanoparticles with antiangiogenic effect for cancer therapy. Nanomaterials (Basel). 2020;10(4:698). doi: 10.3390/nano10040698.
   PubMedGoogle Scholar
• Chang PY, Peng SF, Lee CY, et al. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells. Int J Oncol. 2013;43(4):1141–1150. doi: 10.3892/ijo.2013.2050.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wu Q, Zhang Z, et al. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 2012;17(5):5972–5987. doi: 10.3390/molecules17055972.
   PubMed Web of Science ®Google Scholar
• El-Gizawy MM, Hosny EN, Mourad HH, et al. Curcumin nanoparticles ameliorate hepatotoxicity and nephrotoxicity induced by cisplatin in rats. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(10):1941–1953. doi: 10.1007/s00210-020-01888-0.
   PubMed Web of Science ®Google Scholar
• Harakeh S, Almuhayawi MS, Akefe IO, et al. Novel pomegranate-nanoparticles ameliorate cisplatin-induced nephrotoxicity and improves cisplatin anti-cancer efficacy in ehrlich carcinoma mice model. Molecules. 2022;27(5:1605). doi: 10.3390/molecules27051605.
   Web of Science ®Google Scholar
• Alotaibi B, Tousson E, El-Masry TA, et al. Ehrlich ascites carcinoma as model for studying the cardiac protective effects of curcumin nanoparticles against cardiac damage in female mice. Environ Toxicol. 2020;63(1):105-113. doi: 10.1002/tox.23016.
   Web of Science ®Google Scholar